Addo has developed and tested vaccinations that protect people from Ebola virus disease and the MERS coronavirus EMC/2012.
[2] She earned her diploma at the London School of Hygiene and Tropical Medicine, during which she researched Candida albicans transmission between HIV-positive people.
[3] Here she investigated the role of Indoleamine 2,3-dioxygenase (IDO) specific T cells as immune system regulators in patients with HIV-1.
Her research group work on clinical management, epidemiology and the immunology of newly emerging infections.
[5] In 2014, Addo was involved with the development of the preparation RVSV-EBOV, an experimental recombinant live vaccination that can be used against Ebola virus disease.
[15] Addo was nominated by the Social Democratic Party as delegate to the Federal Convention for the purpose of electing the President of Germany in 2022.